Momenta shares drop on patent loss to Teva – Boston Herald
Shares of Cambridge biotechnology company Momenta Pharmaceuticals dropped as low as nearly 22 percent this morning in the wake of the company losing a patent litigation decision brought by Teva Pharmaceutical Industries. Company stock, which closed Friday ...
Subscribe to LegalLaw247.Com Newsletter